Kazia Therapeutics (KZIA) Assets Average (2009 - 2025)
Kazia Therapeutics' (KZIA) quarterly Assets Average came in at $25.3 million in Q4 2025, up 94.97% YoY from $13.0 million in Q4 2024, and up 224.29% on a QoQ basis from $7.8 million in Q2 2025.
Kazia Therapeutics (KZIA) Assets Average (2009 - 2025) Analysis & Trends
Kazia Therapeutics (KZIA) has 17 years of Assets Average data on file, last reported at $25.3 million in Q4 2025.
- Quarterly Assets Average rose 94.97% year-over-year to $25.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25.3 million (up 94.97% YoY) and the FY2025 annual result came in at $9.1 million, down 45.13% from the prior year.
- Assets Average grew to $25.3 million in Q4 2025, from $7.8 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $38.6 million in Q4 2021 to a low of $7.8 million in Q2 2025.
- A 5-year average of $22.2 million and a median of $19.9 million in 2022 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2021 — Assets Average jumped 153.03% — and 2025, when it slumped 48.19%.
- Tracing KZIA's Assets Average over 5 years: stood at $38.6 million in 2021, then plunged by 44.77% to $21.3 million in 2022, then dropped by 18.82% to $17.3 million in 2023, then dropped by 25.13% to $13.0 million in 2024, then soared by 94.97% to $25.3 million in 2025.
- The last three Assets Average figures came in at $25.3 million (Q4 2025), $7.8 million (Q2 2025), and $13.0 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25.29 Mn |
| Jun 30, 2025 | 7.80 Mn |
| Dec 31, 2024 | 12.97 Mn |
| Jun 30, 2024 | 15.05 Mn |
| Dec 31, 2023 | 17.32 Mn |
| Jun 30, 2023 | 18.53 Mn |
| Dec 31, 2022 | 21.34 Mn |
| Jun 30, 2022 | 28.46 Mn |
| Dec 31, 2021 | 38.64 Mn |
| Jun 30, 2021 | 36.84 Mn |
| Dec 31, 2020 | 22.04 Mn |
| Jun 30, 2020 | 14.56 Mn |
| Dec 31, 2019 | 14.42 Mn |
| Jun 30, 2019 | 16.60 Mn |
| Dec 31, 2018 | 19.85 Mn |
| Jun 30, 2018 | 33.63 Mn |
| Dec 31, 2017 | 36.45 Mn |
| Jun 30, 2017 | 27.67 Mn |
| Dec 31, 2016 | 27.59 Mn |
| Jun 30, 2016 | 30.01 Mn |